Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2913301rdf:typepubmed:Citationlld:pubmed
pubmed-article:2913301lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C0028247lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C1373147lld:lifeskim
pubmed-article:2913301lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2913301pubmed:issue2lld:pubmed
pubmed-article:2913301pubmed:dateCreated1989-3-8lld:pubmed
pubmed-article:2913301pubmed:abstractTextIn an attempt to identify a soluble oncodazole analogue that could be easily formulated, a series of substituted oncodazoles was synthesized and evaluated for tubulin binding affinity, in vitro cytotoxicity against cultured mouse B-16 cells, and ability to prolong lifespan at the maximally tolerated dose in the P388 mouse leukemia model. Biological evaluation of all the isomeric methyloncodazoles demonstrated the thiophene 4'-position to be the only site of significant bulk tolerance, although substitution of this position with polar or charged functional groups abolished biological activity. Simple esters of the 4'-carboxymethyloncodazole were shown to have enhanced antitumor activity and tubulin binding affinity relative to oncodazole. Despite a failure of this study to identify a water-soluble oncodazole with antitumor activity, the structure-activity relationship developed led to a derivative with enhanced activity in the P388 leukemia model and facilitated the preparation of a biologically active photolabile analogue.lld:pubmed
pubmed-article:2913301pubmed:languageenglld:pubmed
pubmed-article:2913301pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2913301pubmed:citationSubsetIMlld:pubmed
pubmed-article:2913301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2913301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2913301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2913301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2913301pubmed:statusMEDLINElld:pubmed
pubmed-article:2913301pubmed:monthFeblld:pubmed
pubmed-article:2913301pubmed:issn0022-2623lld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:JohnsonRRlld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:KruseL ILIlld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:McCabeF LFLlld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:FaucetteLLlld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:MongS MSMlld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:HarrschP BPBlld:pubmed
pubmed-article:2913301pubmed:authorpubmed-author:LaddD LDLlld:pubmed
pubmed-article:2913301pubmed:issnTypePrintlld:pubmed
pubmed-article:2913301pubmed:volume32lld:pubmed
pubmed-article:2913301pubmed:ownerNLMlld:pubmed
pubmed-article:2913301pubmed:authorsCompleteYlld:pubmed
pubmed-article:2913301pubmed:pagination409-17lld:pubmed
pubmed-article:2913301pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:meshHeadingpubmed-meshheading:2913301-...lld:pubmed
pubmed-article:2913301pubmed:year1989lld:pubmed
pubmed-article:2913301pubmed:articleTitleSynthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues.lld:pubmed
pubmed-article:2913301pubmed:affiliationDepartment of Medicinal Chemistry, Smith Kline & French Laboratories, Swedeland, Pennsylvania 19406.lld:pubmed
pubmed-article:2913301pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2913301lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2913301lld:pubmed